Literature DB >> 12873904

Treatment of melanoma in situ on sun-damaged skin with topical 5% imiquimod cream complicated by the development of invasive disease.

Galen H Fisher, Pearon G Lang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12873904     DOI： 10.1001/archderm.139.7.945

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  7 in total

Review 1.  The role of topical immune response modifiers in skin cancer.

Authors:  Courtney Woodmansee; Jessica Pillow; Robert B Skinner
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 2.  Topical imiquimod: a review of its use in the management of anogenital warts, actinic keratoses, basal cell carcinoma and other skin lesions.

Authors:  Antona J Wagstaff; Caroline M Perry
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  Topical Imiquimod Treatment of Lentigo Maligna.

Authors:  F Ventura; J Rocha; J C Fernandes; F Pardal; C Brito
Journal:  Case Rep Dermatol       Date:  2009-10-31

4.  Melanoma in Situ Treated with Topical Imiquimod for Management of Persistently Positive Margins: A Review of Treatment Methods.

Authors:  Qing Fan; Stephanie Cohen; Becky John; Adam I Riker
Journal:  Ochsner J       Date:  2015

Review 5.  [Precancerous and early invasive carcinomas: non-surgical treatment of head and facial skin].

Authors:  E Haneke
Journal:  HNO       Date:  2009-04       Impact factor: 1.284

6.  Combination therapy of imiquimod and gentian violet for cutaneous melanoma metastases.

Authors:  Jack L Arbiser; Maria Bips; Anne Seidler; Michael Y Bonner; Charles Kovach
Journal:  J Am Acad Dermatol       Date:  2012-08       Impact factor: 11.527

7.  Observational study of topical imiquimod immunotherapy in the treatment of difficult lentigo maligna.

Authors:  E E Craythorne; C M Lawrence
Journal:  Clin Med Oncol       Date:  2008-12-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.